InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Chu Yu-Waye. Director active across 2 companies, notably Fate Therapeutics INC. Cumulatively, 12 reports have been published. Split: 0 buy · 6 sells. Total volume traded: €445k. History available since 19 November 2021. The latest transaction was filed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Chu Yu-Waye
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
21,279 shares@ US$6.42398.2% of flowCommon StockSEC:0001610717-26-000125:0
75,000 shares0Common StockSEC:0001610717-26-000042:0
4,025 shares@ US$0.599100.0% of flowCommon StockSEC:0001610717-25-000084:0
56,000 shares0Common StockSEC:0001610717-25-000018:0
26,250 shares0Common StockSEC:0001610717-24-000031:0
215 shares@ US$6.520.2% of flowCommon StockSEC:0001209191-23-024820:0
7,825 shares@ US$5.245.5% of flowCommon StockSEC:0001209191-23-002974:0
4,062 shares@ US$35.3730.8% of flowCommon StockSEC:0001209191-22-025159:0
33,302 shares0Common StockSEC:0000899243-22-003448:0
3,547 shares@ US$48.4435.1% of flowCommon StockSEC:0001209191-22-003166:0
7,500 shares@ US$16.3225.1% of flowCommon StockSEC:0001209191-21-069313:0
60,958 shares0Common StockSEC:0001209191-21-066156:0
12 of 12 declarations
About Chu Yu-Waye
Chu Yu-Waye is a declarant linked to Fate Therapeutics INC, where the role is Chief Medical Officer, and to CytomX Therapeutics, Inc., where the role is Chief Medical Officer. Across 12 filings in total, the 12 sampled filings span 2021-11-22 to 2026-03-19 and show EUR 445281 in sales and EUR 0 in purchases, with Cession as the modal transaction nature.
